URSAPHARM Arzneimittel GmbH: Acting worldwide on behalf of public health

For more than 30 years now, the name URSAPHARM has stood for the con­­sis­tent transfer of innovative phar­­ma­­­­ceu­­tical concepts into successful me­­­­di­­cinal products and medical de­­vices. Today, URSAPHARM is a internatio­­nal operating medium-sized company, headquartered in Saar­­brücken and ranks among the market leaders in ophthalmology in Ger­many. Spe­­cial fo­­­­cus is placed on the treatment of the dry-eye syndrome (Sicca syndrome). URSAPHARM was the first to discover and explore the need to eli­­mi­nate po­­tentially harmful preser­­vatives from multidose units of ophtalmological solutions. Medicinal products for use in general medicine complete the portfolio of URSAPHARM, like the enzyme preparation Brome­lain-POS® for edema treatment.